By Lorenzo

Le Pillole di De Lorenzo # 3: the increase in sales and turnover of industries

Le Pillole di De Lorenzo # 3: the increase in sales and turnover of industries

Behind the bribes taken by De Lorenzo for having imposed the mandatory hepatitis B vaccination, there was a huge gain from two pharmaceutical companies and often the numbers are not properly quoted.

Merck Sharp & Dohme, with the Recombivax vaccine, went from:

  • 2.104 packs sold in 1988
  • 45.952 packs sold in 1989
  • 106.007 packs sold in 1990
  • 466.000 packs sold in 1991
  • 1.400.000 packs sold in 1992

Smithkline Beecham, with Engerix B vaccine, went from:

  • 4.720 packs sold in 1987
  • 138.836 packs sold in 1988
  • 241.000 packs sold in 1983
  • 288.000 packs sold in 1990
  • 1.600.000 packs sold in 1991
  • 4.484.000 packs sold in 1992

In terms of turnover, things are even more conspicuous.

Merck Sharp & Dohme, with the Recombivax vaccine, went from:

  • 880 million Lire of turnover in 1989
  • 2.2 billion Lire of turnover in 1990
  • 6.8 billion Lire of turnover in 1991
  • 20 billion Lire of turnover in 1992

Smithkline Beecham, with Engerix B vaccine, went from:

  • 7.6 billion Lire of turnover in 1989
  • 13 billion Lire of turnover in 1990
  • 40 billion Lire of turnover in 1991
  • 89 billion Lire of turnover in 1992

Corvelva

Publish the Menu module to "offcanvas" position. Here you can publish other modules as well.
Learn more.